PRESS RELEASE: Maryland Oncology Hematology is Now Offering Advanced Radiation Services

PRESS RELEASE: Maryland Oncology Hematology is Now Offering Advanced Radiation Services
PRESS RELEASE: Maryland Oncology Hematology is Now Offering Advanced Radiation Services

Maryland Oncology Hematology is Partnering with Adventist HealthCare to Offer Comprehensive Care that Includes Advanced Radiation Services at the White Oak Cancer Center

Dr. Luqman Dad will lead The Center of Advanced Radiation Oncology and provide state-of-the-art radiation services and technologies to patients in the region.

Maryland, October 20, 2020 – Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, has partnered with Adventist HealthCare to open The Center for Advanced Radiation Oncology at White Oak Cancer Center.

Led by radiation oncologist Luqman Dad, MD, the Center for Advanced Radiation Oncology at White Oak will work alongside the team at Maryland Oncology Hematology to offer compassionate, patient-centered, state-of-the-art radiation therapy. The center will offer seamless delivery of high-quality precise treatment by expert specialists, providing some of the latest in techniques and technologies, including: SBRT, IMRT, IGRT, SRS, and Brachytherapy, along with access to hyperbaric oxygen chamber for late toxicities and radiosensitization of recurrent tumors. The Center for Advanced Radiation Oncology will be located in the White Oak Cancer Center, where patients can have access to a comprehensive multidisciplinary approach to cancer including medical oncology/hematology, radiation oncology, surgical oncology, PET/CT imaging, genetics, research, nutrition, palliative care, social work, physical, occupational and speech rehabilitation.

Dr. Dad brings years of leadership and academic study to The Center of Advanced Radiation Oncology at White Oak Cancer Center. Born at the original Washington Adventist Hospital, Dr. Dad grew up just down the road from the White Oak Cancer Center and attended Paint Branch High School. He completed his undergraduate and medical studies at Boston University. In 2011, Dr. Dad returned to Maryland following the completion of his post-graduate training in Radiation Oncology at Roswell Park Cancer Institute. The Washington Metropolitan area remains close to his heart.

Medical Director, Radiation Oncology

 

“I’m proud to live in a community with great culture, diversity, and opportunities where we can make a tremendous impact and deliver top-notch cancer care,” said Dr. Dad, Medical Director at The Center for Advanced Radiation at White Oak. “At The Center for Advanced Radiation, we’re excited to provide personalized, innovative cancer treatments using the latest technologies.”

 

Dr. Luqman Dad serves as the Medical Director at The Center for Advanced Radiation Oncology at White Oak. He performs numerous procedures to treat patients at all stages of cancer care and is skilled in advanced radiation techniques, including stereotactic body radiation therapy (SBRT), intracranial radiosurgery (SRS), proton beam therapy, gynecologic high-dose rate (HDR) brachytherapy, and more. He is board certified in radiation oncology.

Through the affiliate partnership with the Maryland Proton Treatment Center (MPTC), Dr. Dad has access to this new advanced treatment that is only available in select cancer centers nationwide. Dr. Dad is able to see patients at the White Oak Cancer Center and collaborate with the team at MPTC if proton beam treatment is indicated for the patient.

Dr. Dad has a special interest in breast, prostate, lung, head and neck, gastrointestinal, lymphoma, and central nervous system malignancies. He has served as a lead physician in helping develop national clinical practice parameters for SBRT, as well as principal investigator on industry-sponsored clinical trials. Dr. Dad is an active member of the American Society for Radiation Oncology (ASTRO), where he serves on national committees and helps ASTRO in the global outreach of radiation oncology to underserved regions of the world.

“I’m looking forward to the opportunity to partner with Maryland Oncology Hematology to provide cutting-edge, evidencebased, patient-centered care to this community,” said Dr. Dad. “I believe that the dynamic location, supported by strong infrastructure and the future vision for the White Oak corridor as a hub for science and technology that will place The White Oak Radiation Oncology Program in a position for tremendous growth and success.”

Opening in November, The Center for Advanced Radiation Oncology at White Oak Cancer Center will be located at 11886 Healing Way Suite 101, Silver Spring, MD, 20904. To learn more or to schedule an appointment, visit MarylandOncology.com or call 301.343.3892.

 

About Maryland Oncology Hematology

 

Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.

 

 

About US Oncology Network

Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.

 

To be distributed to local media:

Practice: Maryland Oncology Hematology

Contact: Mark Lamplugh

Phone : 561-762-9729

Email : mark.lamplugh@usoncology.com

Facebooktwitterlinkedinmail
Please Share

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

United in Healing with The US Oncology Network - Maryland Oncology Hematology